Acadian Asset Management LLC Agios Pharmaceuticals, Inc. Transaction History
Acadian Asset Management LLC
- $32.5 Billion
- Q2 2024
A detailed history of Acadian Asset Management LLC transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Acadian Asset Management LLC holds 864 shares of AGIO stock, worth $41,515. This represents 0.0% of its overall portfolio holdings.
Number of Shares
864Holding current value
$41,515% of portfolio
0.0%Shares
5 transactions
Others Institutions Holding AGIO
# of Institutions
226Shares Held
56.3MCall Options Held
275KPut Options Held
251K-
Farallon Capital Management LLC San Francisco, CA5.65MShares$272 Million1.18% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.5MShares$264 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$233 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.88MShares$186 Million2.8% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.78MShares$133 Million0.01% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $2.63B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...